Inventor · disambiguated record
Shawn P. Iadonato
Also filed as: IADONATO SHAWN · IADONATO SHAWN P
28 granted patents·24 pending applications·73 citations·filing 2000–2022
95Inventor score
Top patents by PatentIndex Score
52 records- 0190US9884876B2Anti-viral compounds, pharmaceutical compositions, and methods of use thereofKINETA INC·Filed 2015·Granted Feb 6, 2018·21 cites·14 claims
- 0285US9408826B2Isoflavone anti-viral compoundsIADONATO SHAWN P·Filed 2011·Granted Aug 9, 2016·4 cites·2 claims
- 0385US8895608B2Sulfonamide anti-viral compoundsIADONATO SHAWN P·Filed 2011·Granted Nov 25, 2014·5 cites·7 claims
- 0484US7732177B2Oligoadenylate Synthetase (OAS)ILLUMIGEN BIOSCIENCES INC·Filed 2006·Granted Jun 8, 2010·6 cites·4 claims
- 0583US8030046B2Mutations in OAS1 genesKINETA TWO LLC·Filed 2008·Granted Oct 4, 2011·4 cites·7 claims
- 0682US9073946B2Anti-viral compoundsKINETA INC·Filed 2013·Granted Jul 7, 2015·3 cites·10 claims
- 0781US8192973B2Detection of mutations in a gene associated with resistance to viral infection, OAS1IADONATO SHAWN P·Filed 2006·Granted Jun 5, 2012·3 cites·1 claims
- 0881US8088907B2Detection of mutations in a gene associated with resistance to viral infection, OAS1IADONATO SHAWN P·Filed 2008·Granted Jan 3, 2012·3 cites·1 claims
- 0980US8551772B2Detection of mutations in a gene associated with resistance to viral infection, OAS1IADONATO SHAWN P·Filed 2011·Granted Oct 8, 2013·3 cites·1 claims
- 1077US9381261B2SHK-based pharmaceutical compositions and methods of manufacturing and using the sameIADONATO SHAWN P·Filed 2012·Granted Jul 5, 2016·4 cites·6 claims
- 1172US9937230B2Ophthalmic uses of toxin-based therapeutic peptides and pharmaceutical compositions thereofKINETA ONE LLC·Filed 2014·Granted Apr 10, 2018·3 cites·12 claims
- 1269US8010295B1System and method for selectively classifying a populationIB Security Holders LLC·Filed 2000·Granted Aug 30, 2011·12 cites·48 claims
- 1368US9301952B2Diarylpyridine anti-viral compoundsIADONATO SHAWN P·Filed 2011·Granted Apr 5, 2016·1 cites·15 claims
- 1468US9163222B2Mutations in OAS1 genesKINETA TWO LLC·Filed 2012·Granted Oct 20, 2015·1 cites·7 claims
- 1565US8883477B2Oligoadenylate synthetase (OAS)KINETA TWO LLC·Filed 2013·Granted Nov 11, 2014·0 cites·14 claims
- 1663US9090947B2Detection of mutations in a gene associated with resistance to viral infection, OAS1KINETA TWO LLC·Filed 2013·Granted Jul 28, 2015·0 cites·7 claims
- 1763US2008154514A1System and method for selectively classifying a populationCUBIST PHARM INC·Filed 2007·Application pending·0 cites
- 1861US8859251B2Oligoadenylate synthetase (OAS)KINETA TWO LLC·Filed 2013·Granted Oct 14, 2014·0 cites·14 claims
- 1961US2006275802A1Mutations in OAS1 genesIADONATO SHAWN P·Filed 2006·Application pending·0 cites
- 2060US2014037717A1Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1KINETA TWO LLC·Filed 2013·Application pending·0 cites
- 2159US8486678B2Pharmaceutical compositions for the treatment of virus infectionIADONATO SHAWN P·Filed 2012·Granted Jul 16, 2013·0 cites·5 claims
- 2258US2012321608A1Detection of mutations in a gene associated with resistance to viral infection, oas1IADONATO SHAWN P·Filed 2012·Application pending·0 cites
- 2357US8951768B2Mutations in OAS1 genesIADONATO SHAWN P·Filed 2011·Granted Feb 10, 2015·0 cites·10 claims
- 2457US8133710B2Oligoadenylate synthetase (OAS)IADONATO SHAWN P·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 2556US2011237501A1Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1IADONATO SHAWN P·Filed 2011·Application pending·0 cites
- 2655US2024132593A1Anti-vista antibodies and uses thereofKINETA INC·Filed 2022·Application pending·0 cites
- 2755US2020270274A1Anti-viral compounds, pharmaceutical compositions, and methods of use thereofKINETA INC·Filed 2020·Application pending·0 cites
- 2853US2016122312A1Anti-viral compounds, pharmaceutical compositions and methods of use thereofKINETA INC·Filed 2014·Application pending·0 cites
- 2952US2009155234A1Detection of mutations in a gene associated with resistance to viral infection, mx1CUBIST PHARM INC·Filed 2006·Application pending·0 cites
- 3051US2007111231A1Detection of mutations in a gene associated with resistance to viral infection, OAS2 and OAS3ILLUMIGEN BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 3150US9956285B2Anti-viral compoundsKINETA INC·Filed 2017·Granted May 1, 2018·0 cites·6 claims
- 3249US2019002477A1Anti-viral compounds, pharmaceutical compositions, and methods of use thereofKINETA INC·Filed 2018·Application pending·0 cites
- 3348US9555106B2Anti-viral compoundsKINETA INC·Filed 2012·Granted Jan 31, 2017·0 cites·8 claims
- 3448US2009186028A1Detection of mutations in a gene associated with resistance to viral infectionILLUMIGEN BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 3548US2015342932A1Anti-viral compoundsKINETA INC·Filed 2015·Application pending·0 cites
- 3647US9878058B2SHK-based pharmaceutical compositions and methods of manufacturing and using the sameKINETA ONE LLC·Filed 2015·Granted Jan 30, 2018·0 cites·6 claims
- 3747US8871799B2Iminochromene anti-viral compoundsIADONATO SHAWN P·Filed 2011·Granted Oct 28, 2014·0 cites·1 claims
- 3846US2005191649A1Detection of mutations in a gene associated with resistance to viral infection, OAS1ILLUMIGEN BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 3946US2014227321A1Anti-viral compoundsKINETA INC·Filed 2012·Application pending·0 cites
- 4045US11612661B2Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditionsKINETA CHRONIC PAIN LLC·Filed 2020·Granted Mar 28, 2023·0 cites·28 claims
- 4144US2013035397A1Anti-Viral CompoundsKINETA INC·Filed 2011·Application pending·0 cites
- 4243US9458492B2Methods and cells for identifying RIG-I pathway regulatorsIADONATO SHAWN P·Filed 2012·Granted Oct 4, 2016·0 cites·11 claims
- 4343US2016331847A1Shk-based pharmaceutical compositions and methods of manufacturing and using the sameKINETA ONE LLC·Filed 2016·Application pending·0 cites
- 4441US2008152650A1Methods and Compositions For Specifically Targeting Human Hepatocellular Carcinoma CellsILLUMIGEN BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 4540US2016338967A1Sustained release depot formulations of therapeutic proteins, and uses thereofKINETA ONE LLC·Filed 2014·Application pending·0 cites
- 4640US2016000869A1Methods of treating ipex syndrome using toxin-based pharmaceutical compositionsKINETA ONE LLC·Filed 2014·Application pending·0 cites
- 4740US2016102099A1Anti-viral compoundsKINETA INC·Filed 2015·Application pending·0 cites
- 4839US9878006B2Treatment of obesity and obesity related disorders by pharmalogical targeting of Kv1.3 potassium channelsUNIV CALIFORNIA·Filed 2016·Granted Jan 30, 2018·0 cites·20 claims
- 4937US8927561B2Pyrimidinedione anti-viral compoundsIADONATO SHAWN P·Filed 2011·Granted Jan 6, 2015·0 cites·2 claims
- 5037US2013039887A1Methods of Identifying and Using Anti-Viral CompoundsKINETA INC·Filed 2011·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →